Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 2.05x is 109% above its 5-year average of 0.98x, near the high end of its 5-year range (-2.60x–3.37x).
2.60% below its 12-month average of 2.10x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): 2.41x.
INTEREST COVERAGE RATIO
2.05x
INTEREST COVERAGE RATIO AVG TTM
2.10x
INTEREST COVERAGE RATIO AVG 3Y
1.74x
INTEREST COVERAGE RATIO AVG 5Y
0.98x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-2.60%
CURRENT VS 3Y AVG
+17.79%
CURRENT VS 5Y AVG
+109.45%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.13x
median of 334 covered companies
CURRENT VS SECTOR MEDIAN
+149.58%
vs the sector median at left
GoodRx Holdings, Inc.
Market Cap
$1.17B
Interest Coverage Ratio
2.05x
TTM Avg
2.10x
3Y Avg
1.74x
5Y Avg
0.98x
Market Cap
$1.15B
Interest Coverage Ratio
1.60x
TTM Avg
1.00x
3Y Avg
0.57x
5Y Avg
0.46x
Market Cap
$1.15B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.20B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.12B
Interest Coverage Ratio
5.51x
TTM Avg
6.14x
3Y Avg
19.44x
5Y Avg
31.00x
Market Cap
$1.12B
Interest Coverage Ratio
-497.79x
TTM Avg
15.03x
3Y Avg
15.03x
5Y Avg
8.31x
Market Cap
$1.22B
Interest Coverage Ratio
N/A
TTM Avg
1.72x
3Y Avg
1.72x
5Y Avg
1.72x
Market Cap
$1.12B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.22B
Interest Coverage Ratio
15.57x
TTM Avg
15.57x
3Y Avg
15.57x
5Y Avg
10.02x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GoodRx Holdings, Inc. (GDRX) | $1.17B | 2.05x | 2.10x | 1.74x | 0.98x |
| Harrow Health, Inc. (HROW)vs › | $1.15B | 1.60x | 1.00x | 0.57x | 0.46x |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.15B | N/A | N/A | N/A | N/A |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.20B | N/A | N/A | N/A | N/A |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.12B | 5.51x | 6.14x | 19.44x | 31.00x |
| Castle Biosciences, Inc. (CSTL)vs › | $1.12B | -497.79x | 15.03x | 15.03x | 8.31x |
| Cronos Group Inc. (CRON)vs › | $1.22B | N/A | 1.72x | 1.72x | 1.72x |
| IRadimed Corporation (IRMD)vs › | $1.12B | N/A | N/A | N/A | N/A |
| Innovage Holding Corp. (INNV)vs › | $1.22B | 15.57x | 15.57x | 15.57x | 10.02x |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.26B | N/A | N/A | N/A | N/A |
Interest Coverage
2.0x
Debt/Equity
0.83
Current Ratio
1.38
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 2.41x |
| 2026-03-31 | 2.00x |
| 2025-12-31 | 2.18x |
| 2025-09-30 | 1.35x |
| 2025-06-30 | 2.58x |
| 2025-03-31 | 2.20x |
| 2024-12-31 | 1.60x |
| 2024-09-30 | 1.65x |
| 2024-06-30 | 1.36x |
| 2024-03-31 | 0.50x |
| 2023-12-31 | -1.23x |
| 2023-09-30 | -2.60x |
| 2023-06-30 | 1.30x |
| 2023-03-31 | 0.86x |
| 2022-12-31 | 0.15x |
| 2022-09-30 | -1.66x |
| 2022-06-30 | -0.58x |
| 2022-03-31 | 3.37x |
| 2021-12-31 | 1.99x |
| 2021-09-30 | 1.18x |
| 2021-06-30 | -0.06x |
| 2021-03-31 | -0.85x |
| 2020-12-31 | -48.17x |
| 2020-09-30 | -9.85x |
| 2020-06-30 | 6.14x |
| 2020-03-31 | 5.06x |
| 2019-12-31 | 3.54x |
| 2019-09-30 | 2.96x |
